Delivery Order W912DR08D0028-0004

Award Date 9/7/09
Potential Completion Date 1/9/17
Potential Value $46K
Federal Agency
ENDIST Baltimore
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
W BETHESDA, MD 20827, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
This federal contract award, valued at $84,507.12, was issued by the Defense Health Agency (DHA) to Stemcell Technologies Inc., a subsidiary of Stemcell Technologies, a Canadian company. The award is for the delivery of STEMCELL reagents to support transplant services. The contract is a firm fixed-price purchase order with an ultimate completion date of April 3, 2025. Stemcell Technologies Inc. is an established supplier of specialized biological materials, lab supplies, scientific equipment,...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Applied Stemcell, Inc. for $9,027.20. The contract, which has no set-aside designation, was awarded on April 27, 2011 for gene editing services to generate customized cell and animal models, including knockout mouse models, reporter cell lines, and stem cell models with disease-associated...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business, for a firm-fixed-price purchase order in the amount of $63,000.00. The contract calls for the use of CRISPR gene editing technology to create two custom induced pluripotent stem cell (iPSC) reporter cell lines - one with dual gene knock-ins for albumin and alpha-fetoprotein, and...
Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Wicell Research Institute, Inc., a non-profit organization. The contract, valued at $187,372.95, is for the provision of human pluripotent stem cell lines, testing, and related services to support the NHLBI's biomedical research initiatives. Wicell Research Institute, a subsidiary of the Wisconsin Alumni Research Foundation, is a global...
This is a $1,405,000.00 firm fixed price purchase order contract awarded by the National Human Genome Research Institute, a component of the Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for services related to beta cell differentiation and cell assays, which aligns with the original solicitation that sought the development of assays to evaluate the differentiation of stem cells into insulin-producing beta cells. No...
This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $11,593.80 award is for the delivery of HU PB MONOCYTES, CRYO, 4X10E7 (2 VIALS), with a completion date of July 15, 2024. The contract has no set-aside designation. Stemcell Technologies Inc. is a supplier of...
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
This is a Firm Fixed Price Purchase Order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. - doing business as Applied Stemcell Inc. - a minority-owned, woman-owned small business. The $12,080.00 contract is for services to provide knockout cell line services. This contract award is not set aside. Based on the agency and the services provided, this contract likely supports NICHD's research on child health and...
  • W912DR08D0028
    Indefinite Delivery Contract
  • W912DR08D0028-0004
    Delivery Order

STEM CELL

Posted 9/7/09, 12:00 AM